These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). de Vega WC; Herrera S; Vernon SD; McGowan PO BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836 [TBL] [Abstract][Full Text] [Related]
44. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease. Holden S; Maksoud R; Eaton-Fitch N; Cabanas H; Staines D; Marshall-Gradisnik S J Transl Med; 2020 Jul; 18(1):290. PubMed ID: 32727475 [TBL] [Abstract][Full Text] [Related]
45. Editorial: CD24 in the regulation of cellular development and disease. Christian SL; Cambridge G Front Immunol; 2024; 15():1374701. PubMed ID: 38476222 [No Abstract] [Full Text] [Related]
46. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery. Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J Front Immunol; 2020; 11():582330. PubMed ID: 33329554 [TBL] [Abstract][Full Text] [Related]
47. Exercise modifies glutamate and other metabolic biomarkers in cerebrospinal fluid from Gulf War Illness and Myalgic encephalomyelitis / Chronic Fatigue Syndrome. Baraniuk JN; Kern G; Narayan V; Cheema A PLoS One; 2021; 16(1):e0244116. PubMed ID: 33440400 [TBL] [Abstract][Full Text] [Related]
49. Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Maya J Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569313 [TBL] [Abstract][Full Text] [Related]
50. Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model. Blomberg J; Gottfries CG; Elfaitouri A; Rizwan M; Rosén A Front Immunol; 2018; 9():229. PubMed ID: 29497420 [TBL] [Abstract][Full Text] [Related]
51. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis. Brenu EW; Huth TK; Hardcastle SL; Fuller K; Kaur M; Johnston S; Ramos SB; Staines DR; Marshall-Gradisnik SM Int Immunol; 2014 Apr; 26(4):233-42. PubMed ID: 24343819 [TBL] [Abstract][Full Text] [Related]
52. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients. Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406 [TBL] [Abstract][Full Text] [Related]
53. Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Du Preez S; Eaton-Fitch N; Smith PK; Marshall-Gradisnik S Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509075 [TBL] [Abstract][Full Text] [Related]
55. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels. Nguyen T; Johnston S; Clarke L; Smith P; Staines D; Marshall-Gradisnik S Clin Exp Immunol; 2017 Feb; 187(2):284-293. PubMed ID: 27727448 [TBL] [Abstract][Full Text] [Related]
56. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome. Yang CA; Bauer S; Ho YC; Sotzny F; Chang JG; Scheibenbogen C J Transl Med; 2018 Aug; 16(1):231. PubMed ID: 30119681 [TBL] [Abstract][Full Text] [Related]
57. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome. Eaton-Fitch N; du Preez S; Cabanas H; Staines D; Marshall-Gradisnik S Syst Rev; 2019 Nov; 8(1):279. PubMed ID: 31727160 [TBL] [Abstract][Full Text] [Related]
58. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964 [TBL] [Abstract][Full Text] [Related]
59. The Reification of the Clinical Diagnosis of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) as an Immune and Oxidative Stress Disorder: Construction of a Data-driven Nomothethic Network and Exposure of ME/CFS Subgroups. Maes M; Kubera M; Stoyanova K; Leunis JC Curr Top Med Chem; 2021 Oct; 21(16):1488-1499. PubMed ID: 34315375 [TBL] [Abstract][Full Text] [Related]
60. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Rivas JL; Palencia T; Fernández G; García M Front Immunol; 2018; 9():1028. PubMed ID: 29867995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]